ML
Therapeutic Areas
MetaCurUm Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Monoclonal Antibody (undisclosed) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Monoclonal Antibody (undisclosed) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Preclinical |